Reply
- PMID: 34432751
- PMCID: PMC8384243
- DOI: 10.1097/IAE.0000000000003258
Reply
Conflict of interest statement
None of the authors has any conflicting interests to disclose.
Comment on
-
CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA.Retina. 2021 Jun 1;41(6):1283-1292. doi: 10.1097/IAE.0000000000003029. Retina. 2021. PMID: 33323903 Free PMC article.
-
Correspondence.Retina. 2021 Sep 1;41(9):e70. doi: 10.1097/IAE.0000000000003257. Retina. 2021. PMID: 34255762 No abstract available.
References
-
- Nourinia R, Ahmadieh H, Nekoei E, et al. . Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity. Retina 2018;38:970–975. - PubMed
-
- Rayess N, Rahimy E, Ying GS, et al. . Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol 2015;159:85–91.e1. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
